Clinical trials
Dialysis clinical trials
Below are recruiting dialysis clinical trials, each written for real people, not researchers. We’re tracking 163 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03629977Recruiting
Timing dialysis in critically ill ICU patients
This study looks at the best timing for starting kidney support treatment (dialysis) in very sick people in the ICU. It may help improve outcomes by comparing different start times.
StockholmAges 18 years+ - NCT03994471RecruitingPhase 3
Testing a new peritoneal dialysis fluid for kidney failure
This Phase 3 trial studies how well a new peritoneal dialysis solution works and whether it is safe. It’s meant for adults with kidney failure who already do a specific type of at-home dialysis.
AalborgAges 18 years+ - NCT06516653Recruiting
Study of VasQ implant for new dialysis fistula support
This study tests a small mesh support called VasQ that is placed around your new fistula to help it heal and stay open longer. It is for people who are getting a new fistula for dialysis access.
Long Beach, CaliforniaAges 18–80 - NCT04381143RecruitingPhase 4
Aspirin to prevent problems in people on dialysis
This trial studies whether taking aspirin can reduce heart and clot-related complications in adults receiving long-term dialysis. It may help by improving blood clotting behavior, but it also requires that aspirin is safe for you.
Fuzhou, FujianAges 18 years+ - NCT04399941Recruiting
Ultrasound inside the blood vessel for dialysis access issues
This trial tests a special type of ultrasound placed inside a blood vessel to better understand problems with dialysis access. It may help doctors find the cause of access malfunction during your diagnostic fistulogram.
Boston, MassachusettsAges 18–85 - NCT04848636Recruiting
Sodium MRI scan to study heart salt changes in kidney disease
This trial uses a special MRI scan (called sodium MRI) to measure salt (sodium) in the heart. It compares people with chronic kidney disease (including those on hemodialysis) to healthy volunteers to understand how kidney disease may affect the heart.
London, OntarioAges 18 years+ - NCT04932148Recruiting
Dialysis support study for people starting hemodialysis
This study tests whether an added dialysis plan can improve health outcomes for adults who are starting hemodialysis (a machine-based form of dialysis). It may help doctors find better ways to support people during their first year of dialysis care.
Concord, New South WalesAges 18 years+ - NCT04968587Recruiting
Compare two ways to clean blood during dialysis
This study compares two methods for removing waste products from the blood in people who need dialysis. It aims to see whether one method works better or is safer during extra-renal (outside the body) blood purification.
MelunAges 18 years+ - NCT05090865Recruiting
Increase dietary potassium before dialysis
This study tests whether eating a higher-potassium diet is safe and helpful for people with early-to-moderate kidney failure who are not yet on dialysis. You may be asked to follow a specific diet plan and have blood tests to monitor potassium and other health markers.
Winnipeg, ManitobaAges 18 years+ - NCT05266092Recruiting
Study kidney disease immune system activity in dialysis patients
This study looks at how the body’s defense systems (immune system and related signals) behave in people with chronic kidney disease. It may help doctors understand what is driving inflammation and related complications in dialysis patients.
OdenseAges 18 years+ - NCT05339139RecruitingPhase 3
Testing citrate blood-thinning during kidney dialysis in adults
This study tests how safe a specific blood thinner called “citrate” is when used during continuous kidney dialysis (CRRT) for people with AKI or kidney failure. If you qualify, your care team will compare citrate safety against standard approaches to see if it’s tolerable and safe.
Little Rock, ArkansasAges 18 years+ - NCT05397392Recruiting
Diagnosis and treatment plan for heart–kidney problems
This study looks at the best way to diagnose and treat different types of heart-and-kidney problems that happen together. It may help you (or your caregiver) get the right classification and treatment approach based on how your heart and kidneys are affected.
NanjingAges 18 years+ - NCT05497518Recruiting
KidneyCARE study for adults with chronic kidney disease
This study is for adults with chronic kidney disease (CKD), including people on dialysis or with a kidney transplant. It aims to better support kidney care by allowing more community access to research.
Danville, PennsylvaniaAges 18–120 - NCT05532878Recruiting
Apixaban dosing study for people on peritoneal dialysis
This study checks how apixaban (a blood thinner) moves through the body in people who are on peritoneal dialysis and have non-valvular atrial fibrillation. It may help confirm the safest and most effective dosing for patients who have little or no remaining kidney function.
ShatinAges 18–80 - NCT06032208Recruiting
Study on expanded dialysis for symptom relief
This study tests whether a different type of dialysis, called expanded dialysis, can improve symptoms like fatigue or discomfort. It is for people who have been on regular hemodialysis for at least 3 months.
Winnipeg, ManitobaAges 18 years+ - NCT06056102RecruitingPhase 1
CAR-T cell therapy to help highly sensitized kidney transplant patients
This trial tests whether a special immune cell treatment (CAR-T cells) can lower the antibodies that make it very hard for you to receive a kidney transplant. If it works, you might become eligible for a transplant sooner.
Boston, MassachusettsAges 18–65 - NCT06065982Recruiting
Study of a method for placing a dialysis catheter (PREDICT)
This study watches how well a certain method (percutaneous) works for placing a peritoneal dialysis (PD) catheter, which is a soft tube used for a type of kidney dialysis. By tracking patients’ experiences before and after the procedure, the study aims to improve care for people with kidney failure.
BrusselsAges 18 years+ - NCT06225544RecruitingPhase 2
Lumasiran for high oxalate patients on hemodialysis
This trial tests a drug called Lumasiran to lower oxalate levels in patients on hemodialysis (a type of kidney dialysis). It may help reduce complications from high oxalate, which can damage organs.
BerlinAges 18–80 - NCT06233838Recruiting
Hemoperfusion study for kidney patients on dialysis
This trial tests a special blood-filtering treatment (hemoperfusion) for people with advanced kidney disease on regular dialysis. It aims to remove harmful substances that standard dialysis may not fully clear.
Fuzhou, FujianAges 18 years+ - NCT06249932RecruitingPhase 4
Empagliflozin for heart failure and end-stage kidney disease
This trial tests whether empagliflozin, a medication for heart failure, can help people who also have end-stage kidney disease and are on dialysis. It aims to see if the drug improves heart function in this group.
Hsinchu, TaiwanAges 20 years+ - NCT06249945RecruitingPhase 4
Empagliflozin for heart failure with preserved ejection fraction and dialysis
This trial tests whether a medicine called empagliflozin (used for diabetes and heart failure) can help people with both heart failure (with preserved pumping ability) and end-stage kidney disease who are on dialysis. The study looks at how the drug affects heart function and overall well-being.
HsinchuAges 20 years+ - NCT06257134Recruiting
Monitoring symptoms to improve quality of life in dialysis patients
This trial tests if regularly tracking symptoms through an electronic system can improve quality of life for people on dialysis. It aims to help patients and their care teams better manage symptoms.
GradignanAges 18 years+ - NCT06314503Recruiting
Safety study of a new peritoneal dialysis device for kidney patients
This trial tests a new device called WEAKID for people on peritoneal dialysis. It aims to see if the device is safe to use. Participants must have been on PD for at least 3 months and have no recent infections or catheter problems.
Modena, ModenaAges 18 years+ - NCT06366230RecruitingPhase 1/Phase 2
Adding urea to final dialysis fluid
This trial tests adding urea to the final dialysis fluid for people with very high urea levels. It aims to make dialysis safer and more effective for those who need it urgently.
San Francisco, CaliforniaAges 18 years+
Hear when a new Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for dialysis?
- Yes. Clin2 currently lists 163 recruiting dialysis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a dialysis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a dialysis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.